MyFinsight
Home
Blog
About
Marketable securities
$216,999,595
(117.96%↑ Y/Y)
Cash and cash
equivalents
$20,935,187
(-9.92%↓ Y/Y)
Prepaid expenses and
other current assets
$4,193,195
(231.12%↑ Y/Y)
Total current assets
$242,127,977
(95.07%↑ Y/Y)
Lease right-of-use
assets, net
$88,615,221
(9335.14%↑ Y/Y)
Property and equipment,
net
$36,346,335
(354.60%↑ Y/Y)
Other assets
$1,646,302
(224.07%↑ Y/Y)
Total assets
$368,735,835
(176.06%↑ Y/Y)
Total liabilities and
stockholders' equity
$368,735,835
(176.06%↑ Y/Y)
Total stockholders'
equity
$246,218,890
(134.55%↑ Y/Y)
Total liabilities
$122,516,945
(328.50%↑ Y/Y)
Accumulated deficit
-$379,553,484
(-51.74%↓ Y/Y)
Accumulated other
comprehensive income
-$163,541
(-111.79%↓ Y/Y)
Additional paid-in capital
$625,877,806
(76.96%↑ Y/Y)
Total long-term
liabilities
$89,555,524
(45919.60%↑ Y/Y)
Total current
liabilities
$32,961,421
(16.07%↑ Y/Y)
Common stock, 0.001 par
value, 100,000,000...
$58,109
(27.12%↑ Y/Y)
Lease liabilities,
net of current
$89,555,524
(45919.60%↑ Y/Y)
Accrued expenses
$16,391,869
(122.74%↑ Y/Y)
Deferred revenue,
current
$12,000,000
(0.00%↑ Y/Y)
Accounts payable
$3,079,714
(-36.00%↓ Y/Y)
Lease liabilities,
current
$1,489,838
(75.38%↑ Y/Y)
Back
Back
Balance Sheet
CAPRICOR THERAPEUTICS, INC. (CAPR)
CAPRICOR THERAPEUTICS, INC. (CAPR)
source: myfinsight.com